NEUROINFLAMMATION
Clinical trials for NEUROINFLAMMATION explained in plain language.
Never miss a new study
Get alerted when new NEUROINFLAMMATION trials appear
Sign up with your email to follow new studies for NEUROINFLAMMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Gadolinium-Free MRI dye shows promise for brain scans
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, made with manganese instead of gadolinium, in 18 adults with known brain lesions (like tumors or multiple sclerosis). The goal was to see if it is safe and can detect lesions as well as current gadolinium-based dyes. Each…
Matched conditions: NEUROINFLAMMATION
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Could talk therapy boost brain function in schizophrenia?
Symptom relief CompletedThis pilot study tested whether adding structured supportive psychotherapy to the antipsychotic risperidone could improve cognitive function and reduce inflammation in 44 hospitalized adults with schizophrenia. Participants received either risperidone plus 12 weekly talk therapy …
Matched conditions: NEUROINFLAMMATION
Phase: NA • Sponsor: Hasanuddin University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Herbal extract shows promise in calming schizophrenia
Symptom relief CompletedThis study tested whether adding ashwagandha extract to standard schizophrenia medication (risperidone) could reduce inflammation and improve symptoms. 80 male patients took part. Researchers measured changes in a blood marker for inflammation (IL-1β) and used a standard symptom …
Matched conditions: NEUROINFLAMMATION
Phase: PHASE2 • Sponsor: Hasanuddin University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Could an arthritis drug ease depression by calming brain inflammation?
Symptom relief CompletedThis study tested whether celecoxib (Celebrex), an anti-inflammatory drug, can reduce brain inflammation in people with major depression. 41 adults with depression received 400 mg of celecoxib daily for 8 weeks. Researchers used PET scans to measure inflammation before and after …
Matched conditions: NEUROINFLAMMATION
Phase: PHASE4 • Sponsor: Stony Brook University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Bee product boosts brain power in seniors? new study tests royal jelly
Symptom relief CompletedThis study tested whether taking royal jelly (a bee product) as a daily supplement for 4 weeks could improve memory and thinking in healthy adults aged 55-70. Researchers measured cognitive test scores and blood markers of inflammation. The goal was to see if royal jelly's anti-i…
Matched conditions: NEUROINFLAMMATION
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Pre-surgery ibuprofen may shield elderly brains from post-op fog
Symptom relief CompletedThis study tested whether giving ibuprofen before hernia surgery helps older adults avoid confusion and memory problems after the operation. Seventy-six men aged 65-84 received either ibuprofen or a placebo before surgery. Researchers measured their thinking skills, pain levels, …
Matched conditions: NEUROINFLAMMATION
Phase: PHASE4 • Sponsor: Mehmet Çiğdem • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Wisdom tooth study probes brain chemicals for clues to pain and anxiety
Knowledge-focused CompletedThis study looked at 40 people having both wisdom teeth removed, two weeks apart. Researchers measured two natural chemicals in the blood—serotonin and kynurenic acid—before and after surgery to see if they relate to pain and anxiety. The goal was to better understand how these c…
Matched conditions: NEUROINFLAMMATION
Phase: NA • Sponsor: Plovdiv Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC